比特币钱包|frontiers in immunology影响因子

作者: 比特币钱包
2024-03-09 22:27:00

Frontiers in Immunology_影响因子(IF)_中科院分区_SCI期刊投稿经验_爱科学

手机版

客户端

登录免费注册

首页

科学资讯中文期刊SCI期刊科学基金科学术语科学笔记科学导航导航标签

《Frontiers in Immunology》

所属分类：首页 > SCI期刊 > 医学

期刊名： Frontiers in Immunology

期刊名缩写：FRONT IMMUNOL

期刊ISSN：1664-3224

E-ISSN：1664-3224

2023年影响因子/JCR分区：7.3/Q1

学科与分区：IMMUNOLOGY - SCIE(Q1)

出版国家或地区：SWITZERLAND

出版周期：

出版年份：0

年文章数：1811

是否OA开放访问：Yes

Gold OA文章占比：99.37%

官方网站：journal.frontiersin.org/journal/immunology

投稿网址：www.frontiersin.org/submission/submissioninfo.aspx

编辑部地址：

《Frontiers in Immunology》中科院JCR分区

2021年12月升级版：

大类小类学科Top综述期刊医学 2区IMMUNOLOGY 免疫学2区是否

2021年12月基础版：

大类小类学科Top综述期刊医学 2区IMMUNOLOGY免疫学2区是否

《Frontiers in Immunology》期刊简介：

待更新

浏览下载本刊EndNote styles

《Frontiers in Immunology》相关链接：

PubMed Central (PMC)链接：PubMed Central

平均审稿速度：网友分享经验：

平均录用比例：网友分享经验：

在线出版周期：

历年SCI影响因子

2015

2016

2017

2018

2019

2020

2021

2022

2023

5.695

6.429

5.511

4.716

5.085

7.561

8.786

7.3

《Frontiers in Immunology》评估说明

《Frontiers in Immunology》发布于爱科学网，并永久归类相关SCI期刊导航类别中，本站只是硬性分析 "《FRONT IMMUNOL》" 杂志的可信度。学术期刊真正的价值在于它是否能为科技进步及社会发展带来积极促进作用。"《FRONT IMMUNOL》" 的价值还取决于各种因素的综合分析。

感觉不错，很赞哦！(

)

此文由爱科学编辑！：首页 > SCI期刊 > 医学 » Frontiers in Immunology

上一期刊Foot and Ankle Surgery

下一期刊Frontiers of Medicine

《Frontiers in Immunology》投稿经验分享

Frontiers in Immunology

Navigation group Top bar navigation Frontiers in Immunology

About us

Who we are MissionValuesHistoryLeadershipAwardsImpact and progress Frontiers' impactProgress Report 2022All progress reportsPublishing model How we publishOpen accessFee policyPeer reviewResearch TopicsServices SocietiesNational consortiaInstitutional partnershipsCollaboratorsMore from Frontiers Frontiers ForumPress officeCareer opportunitiesContact us All journalsAll articles Submit your research Search Frontiers in Immunology

Sections

Alloimmunity and TransplantationAntigen Presenting Cell BiologyAutoimmune and Autoinflammatory Disorders : Autoimmune DisordersAutoimmune and Autoinflammatory Disorders: Autoinflammatory DisordersB Cell BiologyCancer Immunity and ImmunotherapyComparative ImmunologyCytokines and Soluble Mediators in ImmunityImmunological MemoryImmunological Tolerance and RegulationInflammationMicrobial ImmunologyMolecular Innate ImmunityMucosal ImmunityMultiple Sclerosis and NeuroimmunologyNK and Innate Lymphoid Cell BiologyNutritional ImmunologyParasite ImmunologyPrimary ImmunodeficienciesSystems ImmunologyT Cell BiologyVaccines and Molecular TherapeuticsViral Immunology ArticlesResearch TopicsEditorial Board

About journal

About us

Sections

About journal

Scope Field chief editorMission & scopeFactsJournal sectionsOpen access statementCopyright statementQualityFor authors Why submit?Article typesAuthor guidelinesEditor guidelinesPublishing feesSubmission checklistContact editorial office Frontiers in Immunology

Sections

About journal

Submit

Guidelines Submit your research

Start your submission and get more impact for your research by publishing with us.

Author guidelines

Ready to publish? Check out our author guidelines for everything you need to know about submission, from choosing a journal and section to preparing your manuscript.

Editor guidelines

Reviewing a manuscript? See our editorial guidelines for everything you need to know about Frontiers’ peer review process.

Peer review

Our efficient and rigorous peer review means you’ll get a decision on your manuscript in just 77 days.

Publishing fees

Article processing charges (APCs) apply to articles that are accepted for publication by our external editors, following rigorous peer review.

Editors See all (13,657) luigi daniele notarangelo Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases (NIH) Bethesda, United States Field Chief Editor

Frontiers in Immunology

adriana albini European Institute of Oncology IEO (IRCCS) Milan, Italy Specialty Chief Editor

Cancer Immunity and Immunotherapy

josep bassaganya-riera Landos Biopharma, Inc. Blacksburg, United States Specialty Chief Editor

Nutritional Immunology

vassiliki a boussiotis Beth Israel Deaconess Medical Center, Harvard Medical School Boston, United States Specialty Chief Editor

Cancer Immunity and Immunotherapy

Articles See all (36,988) Editorial

Accepted on 08 Mar 2024

Editorial: Women in Cytokines and Soluble Factors in Immunity

in Cytokines and Soluble Mediators in Immunity Diana BoraschiGiselle Penton-RolOlukemi AmoduMarita Troye Blomberg Frontiers in Immunology doi 10.3389/fimmu.2024.1395165 Original Research

Accepted on 08 Mar 2024

Reduced serum IgG galactosylation is associated with increased inflammation during relapses of neuromyelitis optica spectrum disorders

in Multiple Sclerosis and Neuroimmunology Shiyu GaoXin JiaoRuoyi GuoXiujuan SongLi GuoBin Li Frontiers in Immunology doi 10.3389/fimmu.2024.1357475 Original Research

Accepted on 08 Mar 2024

Deconvolution of synovial myeloid cell subsets across pathotypes and role of COL3A1+ macrophages in rheumatoid arthritis remission

in Autoimmune and Autoinflammatory Disorders : Autoimmune Disorders Xuantao HuZiji ZhangLingli LongWeishen ChenBaiqi PanXiaoyu WuChao WangChengxin LiLinli ZhengPuyi Sheng Frontiers in Immunology doi 10.3389/fimmu.2024.1307748 Editorial

Accepted on 08 Mar 2024

Editorial: Towards a Better Understanding of Hemophagocytic Lymphohistiocytosis (HLH)

in Autoimmune and Autoinflammatory Disorders : Autoimmune Disorders Sabrin Albeituni Frontiers in Immunology doi 10.3389/fimmu.2024.1385487 Volumes See all (15)

Volume 15 - 2024

Volume 14 - 2023

Volume 13 - 2022

Volume 12 - 2021

Volume 11 - 2020

Research Topics See all (2,723)

Submission open

Exploring Lymphocyte Signaling: From Health to Disease Luca SimeoniRosa Molfetta

Submission open

The Two Faces of the Aryl Hydrocarbon Receptor: Cancer and Autoimmunity David H SherrChristiane A. OpitzChristoph F A VogelFrancisco Javier Quintana

Submission open

Mechanisms and Therapeutic Opportunities of T Cell Impairment in Cancer Immunity and Immunotherapy Guillaume BeyrendWantao WuRaquel Alarcon Rodriguez

Submission open

The Current State of Knowledge on Asthma-COPD Overlap (ACO) in Clinical and Experimental Research: What Do We Know So Far? Fernanda Degobbi Tenorio Quirino dos Santos LopesPaulo CardosoCelso RF CarvalhoLucy C FaircloughIolanda de Fátima Lopes Calvo TibérioRenata Kelly Da PalmaAna Paula Ligeiro De OliveiraRenato Fraga Righetti Learn more about Research Topics Footer Guidelines Author guidelinesEditor guidelinesPolicies and publication ethicsFee policy Explore ArticlesResearch Topics Journals Outreach Frontiers Forum Frontiers Policy Labs Frontiers for Young Minds Connect Help centerEmails and alerts Contact us SubmitCareer opportunities Follow us © 2024 Frontiers Media S.A. All rights reserved Privacy policy | Terms and conditions

会不会被中科院预警？影响因子8+，年发文量超7000+ - 知乎

会不会被中科院预警？影响因子8+，年发文量超7000+ - 知乎首发于学术期刊知识普及切换模式写文章登录/注册会不会被中科院预警？影响因子8+，年发文量超7000+千言文化已认证账号今天介绍的又是一本热门期刊：Frontiers in immunology，杂志创刊于2010年，对这本期刊大家疑问最多的就是：杂志是不是水刊？会不会被预警？中科院已确定2023版预警期刊名单（试行）将会在1月初发布，我们后续也会给大家实时更新，以下是对该期刊的详细介绍。1、影响因子2021-2022年最新影响因子为8.786，杂志这几年的影响因子分值一直在6-8分上下，对国内医生来说投稿也会有一定难度，但是对申请课题、晋升职称来说帮助很大！2、JCR&中科院分区JCR分区在162本同领域免疫学期刊中排名35，属于Q1区。中科院分区基础版：大类学科-医学2区，小类-免疫学2区；升级版：大类学科-医学2区，小类-免疫学2区。3、发文量WOS网站显示，杂志的发文量一直呈上升趋势，2022年发文量已经达到惊人的7392篇！早在2016年发文量为679篇，2017年起开始扩刊，涨到1884篇，发文量迎来指数级增长。4、审稿周期该刊年刊文量虽大，审稿接收速度可不慢，以最新发表的几篇文章为例：稿件1：投稿到接收40天，接收到发表12天。稿件2：投稿到接收7个月，接收到发表15天。稿件3：投稿到接收2个月，接收到发表15天。可以看出，如果投稿顺利、返修次数少的话，投稿到接收40天就可以完成。5、发表费用作为一本OA期刊，仍是需要作者为论文支付一次性文章处理费（APC），而且是按照发表文章类型进行收费。一般大家发表和关注比较多的临床试验、原创性研究、综述性文章、系统综述等属于A类文章，版面费3225美元，相当于人民币22135元左右(汇率波动)；简短的研究报告、病例报告、小综述等属于B类文章，版面费2020美元，约合人民币13864元。6、自引率目前2021-2022年最新自引率为10%，这个自引率还是比较高的，一般自引率低于10%安全性比较高，否则影响因子水分较大。7、国人发文占比该刊的年刊文量够高，其中刊文量排名前十的国家或地区，第一位是美国学者，发文量占比27.844%。中国学者第二，发文量占比26.166%，但相比早年还是涨了不少的。8、基本信息期刊ISSN：1664-3224；出版商：Frontiers Media S.A.出版期刊官网：http://journal.frontiersin.org/journal/immunology；投稿网址：http://www.frontiersin.org/submission/submissioninfo.aspx；是否OA开放：Yes9、期刊总结Journal of Translational Medicine的优势很明显：JCR一区期刊，8分+的影响因子、年发文量超高，这对很多有高分SCI发表需求的小伙伴来说，是个可以考虑的刊物。不过很多人也对期刊的预警情况持观望态度，大家也可以等待最新预警期刊名单公布再做选择。编辑于 2023-01-09 10:55・IP 属地江苏高影响因子中国科学院科研赞同 1添加评论分享喜欢收藏申请转载文章被以下专栏收录学术期刊知识普及普及学术知识，揭露刊物真相，探寻靠

帮助大家简单分析一下最近大火的frontiers in immunology. - 知乎

帮助大家简单分析一下最近大火的frontiers in immunology. - 知乎切换模式写文章登录/注册帮助大家简单分析一下最近大火的frontiers in immunology.起风了生信分析，计算机，实验Need help? Contact帮助大家简单分析一下最近大火的frontiers in immunology.目前这个杂志影响因子是8.7分，中科院分区是中科院二区，目前版面费是2950美元每年的出版量在5000以上目前全世界很多名牌大学和院校都发了不少文章。国内来看，中国科学院发文量最大为416篇。所以不用担心这个杂志进入中科院黑名单。这个杂志目前对中国人非常友好，而且整体文章质量非常好。最近2年可能上十分成为中科院一区杂志。这个杂志非常非常好的地方在于文章接受后马上出版这个杂志投稿的注意事项。第一：投稿的时候一定要上传原始数据到supplement的栏目里面。否则过不了初审。第二：文章接受后会收到很多诈骗短信，说主编生病了需要你把钱转到私人账户。这个是骗子，一定要注意。发布于 2022-09-01 10:35SCI投稿赞同 1028 条评论分享喜欢收藏申请

Frontiers in Immunology - 科研通

SciHub

文献互助

期刊查询

一搜即达

科研导航

交流社区

发布文献求助

首页

我的求助

捐赠本站

期刊查询

期刊详情 2023年中科院分区 | 2024年《国际期刊预警名单》已更新

Frontiers in Immunology

期刊全称

Frontiers in Immunology

期刊缩写

Front. Immunol.

涉及主题

（科研通AI识别）

生物

医学

遗传学

免疫学

内科学

化学

生物化学

免疫系统

病理

基因

细胞生物学

抗原

受体

抗体

炎症

体外

疾病

内分泌学

癌症研究

期刊介绍

Frontiers in Immunology is a leading journal in its field, publishing rigorously peer-reviewed research across basic, translational and clinical immunology. Field Chief Editor Luigi Daniele Notarangelo is supported by an outstanding Editorial Board of international researchers. This multidisciplinary open-access journal is at the forefront of disseminating and communicating scientific knowledge and impactful discoveries to researchers, academics, clinicians and the public worldwide.

Frontiers in Immunology is the official Journal of the International Union of Immunological Societies (IUIS). Encompassing the entire field of Immunology, this journal welcomes papers that investigate basic mechanisms of immune system development and function, with a particular emphasis given to the description of the clinical and immunological phenotype of human immune disorders, and on the definition of their molecular basis.

期刊ISSN

print: 1664-3224

2022最新影响因子 (2023年6月28日公布)与上一年的差值

7.3↓ 1.486

历年影响因子

2022年

2021年

2020年

2019年

2018年

2017年

2016年

2015年

7.3

8.786

7.561

5.085

4.716

5.511

6.429

5.695

历年发表/被引量（科研通AI通过大数据分析）

年份20222021202020192018201720162015201420132012

发表量71536185355531063179192668310496941730426

被引量14848513737389318510683021918524139171052957872582432

h-index（2021）

自引率

11.00%

涉及的研究领域

IMMUNOLOGY-

WOS期刊分区（2023年6月28日公布）

学科分类

Q1IMMUNOLOGY

中科院SCI期刊分区（2023年12月升级版）

大类

小类

TOP期刊

综述期刊

2区医学

2区免疫学IMMUNOLOGY

否

中科院SCI期刊分区（2022年12月升级版）

大类

小类

TOP期刊

综述期刊

2区医学

2区免疫学IMMUNOLOGY

是

否

中科院SCI期刊分区（2021年12月基础版）

大类

小类

TOP期刊

综述期刊

2区医学

2区免疫学IMMUNOLOGY

是

否

中科院SCI期刊分区（2021年12月升级版）

大类

小类

TOP期刊

综述期刊

2区医学

2区免疫学CIMMUNOLOGY

是

否

中科院《国际期刊预警名单（试行）》名单

2024年02月发布的2024版：不在预警名单中2023年01月发布的2023版：不在预警名单中2021年12月发布的2021版：不在预警名单中2021年01月发布的2020版：不在预警名单中

期刊主页

http://journal.frontiersin.org/journal/immunology

投稿网址

http://www.frontiersin.org/submission/submissioninfo.aspx

编辑部地址

AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, SWITZERLAND, CH-1015

出版商

Frontiers Media S.A.

出版国家（地区）

SWITZERLAND

出版语言

English

出版周期

每年出版文章数

5759

Gold OA文章占比

99.46%

原创研究文献占比（排除综述）

72.57%

SCI收录类型

Science Citation Index Expanded (SCIE)Scopus (CiteScore)Directory of Open Access Journals (DOAJ)

PubMed链接

http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1664-3224%5BISSN%5D

平均审稿周期

网友分享经验：14 Weeks

平均录用比例

网友分享经验：

期刊介绍 | Frontiers 出版社官方中文网站

首页

期刊介绍

出版费用

前沿专刊

联系我们

Frontiers 出版社官方中文网站

首页

期刊介绍

出版费用

前沿专刊

联系我们

期刊介绍

ABCDEFGHIJKLMNOPQRSTUVWXYZ

Frontiers in Aging Neuroscience

影响因子：4.362

Frontiers in Agronomy

Frontiers in Applied Mathematics and Statistics

Frontiers in Artificial Intelligence

Frontiers in Astronomy and Space Sciences

Frontiers in Behavioral Neuroscience

影响因子：2.512

Frontiers in Big Data

Frontiers in Bioengineering and Biotechnolog

影响因子：3.644

Frontiers in Blockchain

Frontiers in Built Environment

Frontiers in Cardiovascular Medicine

影响因子：3.915

Frontiers in Cell and Developmental Biology

影响因子：5.201

Frontiers in Cellular and Infection Microbiology

影响因子：4.123

Frontiers in Cellular Neuroscience

影响因子：3.921

Frontiers in Chemical Engineering

Frontiers in Chemistry

影响因子：3.693

Frontiers in Climate

Frontiers in Communication

Frontiers in Computational Neuroscience

影响因子：2.535

Frontiers in Computer Science

Frontiers in Digital Health

Frontiers in Digital Humanities

Frontiers in Earth Science

影响因子：2.689

Frontiers in Ecology and Evolution

影响因子：2.416

Frontiers in Education

Frontiers in Endocrinology

影响因子：3.644

Frontiers in Energy Research

影响因子：2.746

Frontiers in Environmental Chemistry

Frontiers in Environmental Science

影响因子：2.749

Frontiers in Evolutionary Neuroscience

Frontiers in Forest and Global Change

Frontiers in Future Transportation

Frontiers in Genetics

影响因子：3.258

Frontiers in Genome Editing

Frontiers in Global Women’s Health

Frontiers in Human Dynamics

Frontiers in Human Neuroscience

影响因子：2.673

Frontiers in Immunology

影响因子：5.085

Frontiers in Integrative Neuroscience

影响因子：2.152

Frontiers in Marine Science

影响因子：3.661

Frontiers in Materials

影响因子：2.705

Frontiers in Mechanical Engineering

Frontiers in Medical Technology

Frontiers in Medicine

影响因子：3.900

Frontiers in Microbiology

影响因子：4.235

Frontiers in Molecular Biosciences

影响因子：4.188

Frontiers in Molecular Neuroscience

影响因子：4.057

Frontiers in Nanotechnology

Frontiers in Neural Circuits

影响因子：3.156

Frontiers in Neuroanatomy

影响因子：3.292

Frontiers in Neuroenergetics

Frontiers in Neuroengineering

Frontiers in Neuroinformatics

影响因子：2.649

Frontiers in Neurology

影响因子：2.889

Frontiers in Neurorobotics

影响因子：2.574

Frontiers in Neuroscience

影响因子：3.707

Frontiers in Nutrition

影响因子：3.365

Frontiers in Oncology

影响因子：4.848

Frontiers in Oral Health

Frontiers in Pediatrics

影响因子：2.634

Frontiers in Pharmacology

影响因子：4.225

Frontiers in Physics

影响因子：2.638

Frontiers in Physiology

影响因子：3.367

Frontiers in Plant Science

影响因子：4.402

Frontiers in Political Science

Frontiers in Psychiatry

影响因子：2.849

Frontiers in Psychology

影响因子：2.067

Frontiers in Public Health

影响因子：2.483

Frontiers in Reproductive Health

Frontiers in Research Metrics and Analytics

Frontiers in Robotics and AI

Frontiers in Sociology

Frontiers in Sports and Active Living

Frontiers in Surgery

影响因子：1.826

Frontiers in Sustainability

Frontiers in Sustainable Cities

Frontiers in Sustainable Food System

Frontiers in Synaptic Neuroscience

Frontiers in Systems Neuroscience

影响因子：3.293

Frontiers in Toxicology

Frontiers in Veterinary Science

影响因子：2.245

Frontiers in Virtual Reality

Frontiers in Water

地址：北京市西城区廊房头条 13 号院 E16 栋 WeWork(北京坊)

联系电话：010 – 8620 8060

邮箱：marketing.china@frontiersin.org

手机访问本页

关注我们的微信公众号

Frontiers in Immunology-期刊介绍-MedSci.cn

资讯

内科

心血管

肿瘤

内分泌

普通内科

消化

呼吸

神经科

传染科

精神心理

肾内科

风湿免疫

血液科

老年医学

外科

头颈外科

胃肠外科

血管外科

肝胆胰外

骨科

普通外科

胸心外科

神经外科

泌尿外科

烧伤科

整形美容

麻醉疼痛

专科科室

罕见病

康复医学

药械

儿科

耳鼻咽喉

口腔科

眼科

政策人文

营养全科

预防公卫

妇产科

中医科

急重症

皮肤性病

影像放射

转化医学

检验病理

护理

热点

临床研究

研究设计

人工智能

智慧医疗

论文基金

医学科普

药物经济

医生集团

职业安全

患者招募

医学科研

公司产业

医学英语

MedSci动态

指南

按科室浏览

肿瘤科

心血管

传染科

妇产科

神经科

儿科

呼吸

内分泌科

血液科

消化

更多科室

工具

临床工具

临床指南

医学计算与公式

ICD-10/ICD-11疾病编码

医迅达

直播

话题

公开课

精品课

科研工具

期刊数据库查询

期刊智能选择

云研究平台

随机化工具

全球基金查询

文献查询

SCI写作宝典

生物医药大词典

其他工具

下载App使用方便更快捷

Medsci 梅斯搜索

公开课

精品课

服务

科研数智化

直播，公开课与精品课

科研加速器

研究者发起的临床研究（IIS）支持

真实世界研究解决方案

药物经济学

医保准入事务

研究方案设计

数据库建立与管理

药物警戒（PV）

真实世界研究执行

数据统计分析

数字化学术传播解决方案

多渠道营销（MCM）

产品医学策略

学术传播（APO）

其它

积分商城

FAQS

FRONT IMMUNOL

润色咨询

Frontiers in Immunology

出版年份：2014

年文章数：22393

投稿命中率：

开通期刊会员，数据随心看

出版周期：Irregular

自引率：11.2%

审稿周期：

开通期刊会员，数据随心看

前往期刊查询

期刊讨论

中国SCI论文

期刊主页

投稿经验

杂志官网

投稿链接

作者需知

PMC链接

Pubmed全文检索

期刊论坛

期刊介绍

期刊解读

热门指数

影响指数

投稿信息

期刊对比

期刊阅读

返回查询

期刊简介

GetPortalImpactFactorByIdResp(projectId=1, id=267f12749, cover=https://img.medsci.cn/images/journal/cover/2021/daB_202109271315055560.jpg, fullname=Frontiers in Immunology, abbr=FRONT IMMUNOL, pyear=2014, frequence=Irregular, articleNumbers=22393, citedSelf2015=11.2, acceptanceRate=null, submissionToAcceptance=null, averageReviewTime=平均2.95月, reviewFee=null, pageFee=2940.0, publishedRatio=2023年中国人文章占该期刊总数量暂无数据 (2022年为100.00%), issn=1664-3224, greenSci=https://www.greensci.net/search?kw=1664-3224, scijournal=https://www.scijournal.org/impact-factor-of-FRONT-IMMUNOL.shtml, medsciHotlightString=null, medsciHotlightRealtime=57.667, medsciHotlight=96.618, medsciHotlight5year=46.4368, citescore=8.1, hIndex=124, impactFactor=7.3, orgnization=Frontiers Media S.A., orgnizationUrl=http://journal.frontiersin.org/, country=Switzerland, countryCn=瑞典, isOa=1, isOaString=是, sciScie=, bigclassCas=医学 2区, smallclassCas=医学 2 区, website=https://www.frontiersin.org/journals/immunology, websiteHits=29396, guideForAuthor=https://www.frontiersin.org/journals/immunology#author-guidelines, guideForAuthorHits=6617, submitWebsite=https://www.frontiersin.org/submission/SubmissionHome.aspx?domainId=2&fieldId=35&specialtyId=0&entityType=1&entityId=276, submitWebsiteHits=17997, content=

Frontiers in Immunology is a peer-reviewed Open Access Journal, and the official Journal of theInternational Union of Immunological Societies (IUIS). It provides a novel way to disseminate the latest findings in basic and translational research in Immunology and to facilitate communication, both among scientists as well as the community at large.
Frontiers in Immunology aims to publish the most outstanding research findings encompassing the entire field of Immunology. In addition to papers that investigate basic mechanisms of immune system development and function, a particular emphasis is given to the description of the clinical and immunological phenotype of human immune disorders, and on the definition of their molecular basis. Furthermore, availability of a growing number of biological drugs, coupled with fine characterization of the molecular mechanisms of disease, has now made precision medicine a desirable approach for many immunological disorders. Frontiers in Immunology intends to portray how advances of scientific knowledge and technology may translate into novel approaches to diagnosis and treatment of immune disorders, both in animal and cellular models and in humans.
All manuscripts submitted to Frontiers in Immunology that report on studies conducted in human subjects must conform with current regulation and the Declaration of Helsinki, and must receive approval from the Institutional Review Board and patient informed consent. Animal welfare and Ethics Committee approval is required for studies involving animals.

Frontiers in Immunology is organized into Specialty Sections that cover different areas of research in Immunology. Authors should refer to the author guidelines for details on article types and the submission process.

, totalCites=163472, brief=FRONT IMMUNOL杂志医学行业，“免疫学”子行业的顶级杂志, articleType=本刊接收类型不明, medsciHeat=红, medsciComment=FRONT IMMUNOL也是国际顶级杂志，属于一流期刊。但在中国知晓度很高，关注人比较多，投稿难度不易，拒稿率不低于70%。但是，一般来说，审稿比较快，如果质量不错的文章还能快速获得一些有价值的审稿意见，便于进一步改进，因此，如果您的文章质量不错的话，MedSci建议您可以试投FRONT IMMUNOL。, medsciExplanation=MedSci期刊指数是根据中国科研工作者（含医学临床，基础，生物，化学等学科）对SCI杂志的认知度，熟悉程度，以及投稿的量等众多指标综合评定而成。当然，具体的，您还可以结合“投稿经验系统”，进行综合判断，这更是大家的实战经验，值得分享和参考。

注意，上述MedSci期刊指数采用MedSci专利技术，由计算机系统自动计算，并给出建议，存在不准确的可能，仅供您投稿选择杂志时参考。, tags=[ImpactFactorTagDto(id=205, tagName=免疫, createdHits=83), ImpactFactorTagDto(id=119, tagName=肿瘤, createdHits=45), ImpactFactorTagDto(id=20213, tagName=肿瘤免疫, createdHits=15), ImpactFactorTagDto(id=3184, tagName=综述, createdHits=12), ImpactFactorTagDto(id=1660, tagName=炎症, createdHits=11), ImpactFactorTagDto(id=57838, tagName=生信, createdHits=8), ImpactFactorTagDto(id=1246, tagName=免疫治疗, createdHits=7), ImpactFactorTagDto(id=41459, tagName=inflammation, createdHits=5), ImpactFactorTagDto(id=65785, tagName=黏膜免疫, createdHits=5), ImpactFactorTagDto(id=2892, tagName=免疫调节, createdHits=4), ImpactFactorTagDto(id=5209, tagName=炎症因子, createdHits=4), ImpactFactorTagDto(id=510, tagName=自身免疫, createdHits=4), ImpactFactorTagDto(id=846, tagName=感染, createdHits=3), ImpactFactorTagDto(id=66238, tagName=营养与免疫, createdHits=3), ImpactFactorTagDto(id=16570, tagName=先天免疫, createdHits=3), ImpactFactorTagDto(id=14116, tagName=细胞免疫, createdHits=2), ImpactFactorTagDto(id=120, tagName=免疫学, createdHits=2), ImpactFactorTagDto(id=43643, tagName=组学, createdHits=2), ImpactFactorTagDto(id=65780, tagName=临床实用性, createdHits=2), ImpactFactorTagDto(id=1450, tagName=T细胞, createdHits=2), ImpactFactorTagDto(id=20275, tagName=公共数据库, createdHits=2), ImpactFactorTagDto(id=49438, tagName=免疫炎症, createdHits=2), ImpactFactorTagDto(id=16713, tagName=光动力, createdHits=2), ImpactFactorTagDto(id=4284, tagName=寄生虫, createdHits=2), ImpactFactorTagDto(id=461325, tagName=消化免疫, createdHits=1), ImpactFactorTagDto(id=439274, tagName=肺癌生信, createdHits=1), ImpactFactorTagDto(id=43029, tagName=biomarker, createdHits=1), ImpactFactorTagDto(id=25, tagName=干细胞, createdHits=1), ImpactFactorTagDto(id=393, tagName=黏膜, createdHits=1), ImpactFactorTagDto(id=462354, tagName=生信免疫, createdHits=1)], citeScoreList=[GetImpactFactorCiteScoreListResponse(year=2016, citescore=5.37), GetImpactFactorCiteScoreListResponse(year=2017, citescore=5.62), GetImpactFactorCiteScoreListResponse(year=2018, citescore=4.71), GetImpactFactorCiteScoreListResponse(year=2019, citescore=5.4), GetImpactFactorCiteScoreListResponse(year=2020, citescore=8.1)], medsciIndexList=[GetImpactFactorMedsciIndexListResponse(year=2020, medsciHotlight=50.585), GetImpactFactorMedsciIndexListResponse(year=2021, medsciHotlight=82.032), GetImpactFactorMedsciIndexListResponse(year=2022, medsciHotlight=126.928), GetImpactFactorMedsciIndexListResponse(year=2023, medsciHotlight=76.313), GetImpactFactorMedsciIndexListResponse(year=2024, medsciHotlight=57.667)], citeScoreGradeList=[GetImpactFactorCiteScoreGradeResponse(smallClass=Medicine - Immunology and Allergy , rank=28/188), GetImpactFactorCiteScoreGradeResponse(smallClass=Immunology and Microbiology - Immunology , rank=35/198)], totalJcrAreaList=[], pmcUrl=https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1664-3224[ISSN], pubmedUrl=https://www.ncbi.nlm.nih.gov/pubmed?cmd=search&term=Frontiers in Immunology[ta], article_number=8165, article_number_cn=3703, earlyWarning=null, linkOutUrl=null, isJournalMember=false, unscrambleContent=null, dayViewCount=false, endexampletyle=暂无数据)

期刊名称

FRONT IMMUNOL/Frontiers in Immunology

ISSN

1664-3224

影响指数话题

预警等级

MedSci期刊指数

57.667

（MedSci实时期刊指数）

| 46.4368

（5年期刊指数）

CiteScore值

8.1

h-index

124

h5-median

暂无数据

出版社/管理机构

杂志由 Frontiers Media S.A. 出版或管理

出版国家/地区

Switzerland 瑞典

出版周期

Irregular

出版年份

2014

是否OA

是

被收录情况

暂无数据

JCR分区

暂无数据

中科院分区

大类：医学 2区

小类：医学 2 区

常用链接

期刊论坛

中国SCI论文

期刊介绍

投稿信息

杂志官网

投稿链接

作者需知

PMC链接

Pubmed全文检索

梅斯医学MedSci-临床医生发展平台

梅斯医学是面向医生的综合互联网平台，应用大数据和人工智能技术链接医生、患者、药械企业等，提供精准数字化医学传播解决方案，优化医疗生态，改善医疗质量，共创美好生活。

关于我们

加入我们

版权合作

投资者关系

MedSci Healthcare

友情链接

我们的业务

真实世界研究

科研数智化

数字化学术传播

我们的产品

期刊智能查询

国自然查询分析

临床指南

医学公式计算

医药生物大词典

梅斯精品课

梅斯公开课

新媒体矩阵

梅斯医学

肿瘤新前沿

血液新前沿

风湿新前沿

呼吸新前沿

皮肤新前沿

神经新前沿

消化新前沿

心血管新前沿

生物谷

MedSci App

增值电信业务经营许可证

备案号沪ICP备14018916号-1

互联网药品信息服务资格证书((沪)-非经营性-2020-0033)

出版物经营许可证

上海工商

上海网警网络110

网络社会征信网

违法和不良信息举报中心

信息举报中心

|违法举报：021-54481353

沪公网安备 31010402000380

本站旨在介绍医药健康研究进展和信息，不作为诊疗方案推荐。如需获得诊断或治疗方面指导，请前往正规医院就诊。

用户应遵守著作权法，尊重著作权人合法权益，不违法上传、存储并分享他人作品。投诉、举报、维权邮箱：editor@medsci.cn，或在此留言

科室

订阅+

更多科室

工具

服务

Frontiers in Immunology-影响指数-MedSci.cn

资讯

内科

心血管

肿瘤

内分泌

普通内科

消化

呼吸

神经科

传染科

精神心理

肾内科

风湿免疫

血液科

老年医学

外科

头颈外科

胃肠外科

血管外科

肝胆胰外

骨科

普通外科

胸心外科

神经外科

泌尿外科

烧伤科

整形美容

麻醉疼痛

专科科室

罕见病

康复医学

药械

儿科

耳鼻咽喉

口腔科

眼科

政策人文

营养全科

预防公卫

妇产科

中医科

急重症

皮肤性病

影像放射

转化医学

检验病理

护理

热点

临床研究

研究设计

人工智能

智慧医疗

论文基金

医学科普

药物经济

医生集团

职业安全

患者招募

医学科研

公司产业

医学英语

MedSci动态

指南

按科室浏览

肿瘤科

心血管

传染科

妇产科

神经科

儿科

呼吸

内分泌科

血液科

消化

更多科室

工具

临床工具

临床指南

医学计算与公式

ICD-10/ICD-11疾病编码

医迅达

直播

话题

公开课

精品课

科研工具

期刊数据库查询

期刊智能选择

云研究平台

随机化工具

全球基金查询

文献查询

SCI写作宝典

生物医药大词典

其他工具

下载App使用方便更快捷

Medsci 梅斯搜索

公开课

精品课

服务

科研数智化

直播，公开课与精品课

科研加速器

研究者发起的临床研究（IIS）支持

真实世界研究解决方案

药物经济学

医保准入事务

研究方案设计

数据库建立与管理

药物警戒（PV）

真实世界研究执行

数据统计分析

数字化学术传播解决方案

多渠道营销（MCM）

产品医学策略

学术传播（APO）

其它

积分商城

FAQS

FRONT IMMUNOL

润色咨询

Frontiers in Immunology

出版年份：2014

年文章数：22393

投稿命中率：

开通期刊会员，数据随心看

出版周期：Irregular

自引率：11.2%

审稿周期：

开通期刊会员，数据随心看

前往期刊查询

期刊讨论

中国SCI论文

期刊主页

投稿经验

杂志官网

投稿链接

作者需知

PMC链接

Pubmed全文检索

期刊论坛

期刊介绍

期刊解读

热门指数

影响指数

投稿信息

期刊对比

期刊阅读

返回查询

期刊简介

影响指数

SCR指数

7.3

SCR指数

学术期刊（JCR impact factor）基于该期刊过去两年中特定期刊发表的全部文章（含article，letter，review）的年平均被引用次数。 SCR指数通常用作替代期刊在其领域内的相对重要性。通常，具有较高影响指数的期刊通常被认为比具有较低影响指数的期刊具有更大的影响力（阅读更多）。

CiteScore评价数据

CiteScore值

8.1

CiteScore分区

Medicine - Immunology and Allergy

28/188

Immunology and Microbiology - Immunology

35/198

CiteScore趋势

常用链接

期刊论坛

中国SCI论文

期刊介绍

投稿信息

杂志官网

投稿链接

作者需知

PMC链接

Pubmed全文检索

梅斯医学MedSci-临床医生发展平台

关于我们

加入我们

版权合作

投资者关系

MedSci Healthcare

友情链接

我们的业务

真实世界研究

科研数智化

数字化学术传播

我们的产品

期刊智能查询

国自然查询分析

临床指南

医学公式计算

医药生物大词典

梅斯精品课

梅斯公开课

新媒体矩阵

梅斯医学

肿瘤新前沿

血液新前沿

风湿新前沿

呼吸新前沿

皮肤新前沿

神经新前沿

消化新前沿

心血管新前沿

生物谷

MedSci App

增值电信业务经营许可证

备案号沪ICP备14018916号-1

互联网药品信息服务资格证书((沪)-非经营性-2020-0033)

出版物经营许可证

上海工商

上海网警网络110

网络社会征信网

违法和不良信息举报中心

信息举报中心

|违法举报：021-54481353

沪公网安备 31010402000380

本站旨在介绍医药健康研究进展和信息，不作为诊疗方案推荐。如需获得诊断或治疗方面指导，请前往正规医院就诊。

用户应遵守著作权法，尊重著作权人合法权益，不违法上传、存储并分享他人作品。投诉、举报、维权邮箱：editor@medsci.cn，或在此留言

科室

订阅+

更多科室

工具

服务

Frontiers in Immunology | About

Navigation group Top bar navigation Frontiers in Immunology

About us

Sections

About journal

About us

Sections

About journal

Sections

About journal

Field chief editor

luigi daniele notarangelo Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases (NIH) Bethesda, United States Field Chief Editor

Frontiers in Immunology

Mission & scope Frontiers in Immunology is a multidisciplinary journal that publishes research across basic, translational, and clinical immunology. The journal aims to showcase advances and novel approaches to diagnosing and treating immune disorders in both animal and cellular models, as well as in humans. Indexed in MEDLINE, PubMed Central, Scopus and the SCIE Frontiers in Immunology is the official Journal of the International Union of Immunological Societies (IUIS).

Led by Field Chief Editor Luigi Daniele Notarangelo (Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, USA), Frontiers in Immunology welcomes contributions that investigate the basic mechanisms of immune system development and function, with a particular emphasis on describing the clinical and immunological phenotype of human immune disorders and defining their molecular basis. Topics include:

advances in biological drugs

immune system development and function

molecular basis of human immune disorders

novel approaches to diagnosis and treatment of immune disorders

precision medicine for immunological disorders

studies on animal and cellular models and in humans

studies on systems immunology with relevant experimental validation.

Frontiers in Immunology particularly welcomes news ideas and approaches which supports and advances the UN’s Sustainable Development Goal (SDGs), specifically SDG 3: good health and well-being. The research published in this journal could lead to the development of new treatments and therapies for various immunological disorders, thereby promoting well-being for all.

Manuscripts that focus on clinical studies, medical treatments, or human diseases without a clear connection to immunology are not suitable for publication in this journal. Additionally, studies that use analytical molecular biology techniques without a clear immunological context or contribution to the field of immunology are also not within the scope of this journal.

Frontiers in Immunology is dedicated to propelling advancements in the field of Immunology by providing unrestricted access to articles and disseminating scientific knowledge to researchers and the public. This enables future scientific breakthroughs.

Ethics Statement

All manuscripts submitted to Frontiers in Immunology that have been conducted in human subjects must conform with current regulations and the Declaration of Helsinki. Ethics committee approval and informed patient consent are required for studies involving human subjects. Institutional animal care and use committee (IACUC) approval is needed for studies involving animals. Phase I - Phase IV clinical trials submitted for publication in Frontiers in Immunology must have been registered with an appropriate public trials registry at the time or before the first patient enrolment. The information on the clinical trial registration (Unique Identifier and URL) must be included in the abstract. Authors are required to disclose all apparent or potential conflicts of interest according to the ICMJE guidelines and those of Frontiers. Facts Short name Front. Immunol. Abbreviation fimmu Electronic ISSN 1664-3224 PMCID All published articles receive a PMCID Impact 7.3 Impact Factor 9.4 CiteScore Indexed in

PubMed, MEDLINE, PubMed Central (PMC), Scopus, Web of Science Science Citation Index Expanded (SCIE), Google Scholar, DOAJ, CrossRef, Chemical Abstracts Service (CAS), Embase, Semantic Scholar, Ulrich's Periodicals Directory, CLOCKSS, EBSCO, OpenAIRE, Zetoc

Journal sections

Frontiers in Immunology is composed of the following Specialty

sections:

Alloimmunity and Transplantation

Antigen Presenting Cell Biology

Autoimmune and Autoinflammatory Disorders : Autoimmune Disorders

Autoimmune and Autoinflammatory Disorders: Autoinflammatory Disorders

B Cell Biology

Cancer Immunity and Immunotherapy

Comparative Immunology

Cytokines and Soluble Mediators in Immunity

Immunological Memory

Immunological Tolerance and Regulation

Inflammation

Microbial Immunology

Molecular Innate Immunity

Mucosal Immunity

Multiple Sclerosis and Neuroimmunology

NK and Innate Lymphoid Cell Biology

Nutritional Immunology

Parasite Immunology

Primary Immunodeficiencies

Systems Immunology

T Cell Biology

Vaccines and Molecular Therapeutics

Viral Immunology

The specialty sections of

Frontiers in Immunology welcome submission of the following

article types:

Addendum, Brief Research Report, Case Report, Classification, Clinical Trial, Conceptual Analysis, Correction, Curriculum, Instruction, and Pedagogy, Data Report, Editorial, General Commentary, Hypothesis & Theory, Methods, Mini Review, Opinion, Original Research, Perspective, Policy and Practice Reviews, Review, Study Protocol, Systematic Review, Technology and Code.

When submitting a manuscript to Frontiers in Immunology, authors must

submit the material directly to one of the specialty

sections. Manuscripts are peer-reviewed by the

Associate and Review Editors of the respective specialty section.

Open access statement Frontiers' philosophy is that all research is for the benefit of humankind. Research is the product of an investment by society and therefore its fruits should be returned to all people without borders or discrimination, serving society universally and in a transparent fashion. That is why Frontiers provides online free and open access to all of its research publications. For more information on open access click here. Open access funder and institutional mandatesFrontiers is fully compliant with open access mandates, by publishing its articles under the Creative Commons Attribution licence (CC-BY). Funder mandates such as those by the Wellcome Trust (UK), National Institutes of Health (USA) and the Australian Research Council (Australia) are fully compatible with publishing in Frontiers. Authors retain copyright of their work and can deposit their publication in any repository. The work can be freely shared and adapted provided that appropriate credit is given and any changes specified.Copyright statement Under the Frontiers Conditions for Website Use and the Frontiers General Conditions for Authors, authors of articles published in Frontiers journals retain copyright on their articles, except for any third-party images and other materials added by Frontiers, which are subject to copyright of their respective owners. Authors are therefore free to disseminate and re-publish their articles, subject to any requirements of third-party copyright owners and subject to the original publication being fully cited. The ability to copy, download, forward or otherwise distribute any materials is always subject to any copyright notices displayed. Copyright notices must be displayed prominently and may not be obliterated, deleted or hidden, totally or partially.Quality Each Frontiers article strives for the highest quality, thanks to genuinely collaborative interactions between authors, editors and reviewers, who include many of the world's best scientists and scholars. Frontiers is well aware of the potential impact of published research both on future research and on society and, hence, does not support superficial review, light review or no-review publishing models.Frontiers uses the single anonymized peer review model, where the reviewer identity is not made visible to the author, while the author identity is visible to the reviewer, and reviewer and the authors’ identities are visible to the decision-making editor. Reviewers interact with the handling editor and the authors. Editor and reviewer names and affiliations are published on all Frontiers articles.Research must be certified by peers before entering a stream of knowledge that may eventually reach the public - and shape society. Therefore, Frontiers only applies the most rigorous and unbiased reviews, established in the high standards of the Frontiers Review System. Furthermore, only the top certified research, evaluated objectively through quantitative online article level metrics, is disseminated to increasingly wider communities as it gradually climbs the tiers of the Frontiers Tiering System from specialized expert readership towards public understanding.Frontiers has a number of procedures in place to support and ensure the quality of the research articles that are published: 2023

Editorial Board Quality

Only leading experts and established members of the research community are appointed to the Frontiers Editorial Boards. Chief Editors, Associate Editors and Review Editors are all listed with their names and affiliations on the Journal pages and are encouraged to publicly list their publication credentials.

Associate Editor Assignment Quality

Associate Editors oversee the peer-review and take the final acceptance decision on manuscripts. Editorial decision power is distributed in Frontiers, because we believe that many experts within a community should be able to shape the direction of science for the benefit of society.

Submitting authors can choose a preferred Associate Editor to handle their manuscript, because they can judge well who would be an appropriate expert in editing their manuscript. There is no guarantee for this preference of choice, Associate Editors can decline invitations any time, and the handling Associate Editor can also be over-ridden by the Chief Editor before she/he is invited to edit the article or at any other stage.

Associate Editors are mandated to only accept to edit a manuscript if they have no conflicts of interest (as stated here and in their review invitation and assignment emails).

Should it become clear that the Associate Editor has a conflict of interest or is unable to perform the peer-review timely and adequately, a new Associate Editor can be assigned to the manuscript by the Chief Editor, who has full control to intervene in the peer-review process at any time.

The Associate Editor initially checks that the article meets basic quality standards and has no obvious objective errors.

Reviewer Assignment Quality

The Associate Editor can then personally choose and invite the most appropriate reviewers to handle the peer-review of the manuscript, including Review Editors from the board or external reviewers.

The Associate Editor is aided in this by the Frontiers Collaborative Review Forum software and interface, which suggests the most relevant Review Editors based on a match between their expertise and the topic of the manuscript. Associate Editors can however choose any reviewer they deem adequate.

After a certain time frame and if no reviewers have in the meantime been assigned to the manuscript, the Frontiers platform and algorithmic safety-net steps in and invites the most appropriate Review Editors based on constantly updated and improved algorithms that match reviewer expertise with the submitted manuscript.

Review Editors and reviewers are mandated to only accept to review a manuscript if they have no conflicts of interest (as stated here and in their review invitation and assignment emails).

Frontiers algorithms are constantly fine-tuned to better match Review Editors with manuscripts, and additional checks are being coded into the platform, for example regarding conflicts of interest.

Should it become clear that a particular reviewer has a conflict of interest or is unable to perform the peer-review timely and adequately, he or she shall be replaced with an alternative reviewer by the Associate Editor or the Chief Editor, who will be alerted and has full control to intervene into the peer-review at any time.

Independent Review Stage Quality

In the Independent Review Stage the assigned reviewers perform an in-depth review of the article independently of each other to safeguard complete freedom of opinion.

The reviewers are aided by an online standardized review questionnaire – adopted to article types – with the goal to facilitate rigorous evaluation according to objective criteria and the Frontiers Review Guidelines.

Interactive Review Stage Quality

The Associate Editor assesses the reviews and activates the “Interactive Review” – informing the authors of the extent of revisions that are required to address the reviewers’ comments, and starting the Interactive Discussion Forum where authors and also the reviewers get full access to all review reports.

Manuscript and review quality at this stage are enhanced by allowing authors and reviewers to discuss directly with each other in real-time until they reach consensus and a final version of the manuscript is endorsed by the reviewers.

Reviewer identity is protected at this stage to safeguard complete freedom of opinion.

Reviewers can recommend rejection at this stage if their requests to correct objective errors are not being met by the authors or if they deem the article overall of insufficient quality.

Should a dispute arise, authors or reviewers can trigger an arbitration and will alert the Associate Editor, who can assign more reviewers and/or bring the dispute to the attention of the Chief Editor. The Associate Editor can also weigh in on the discussion and is asked to mediate the process to ensure a constructive revision stage.

Decision Stage Quality

The decision to accept an article needs to be unanimous amongst all reviewers and the handling Associate Editor.

The names of the Associate Editor and reviewers are disclosed on published articles to encourage in depth and rigorous reviews, acknowledge work well done on the article and to bring transparency and accountability into peer-review.

Associate Editors can recommend the rejection of an article to the Chief Editor, who needs to check that the authors’ rights have been upheld during the peer-review process, and who can then ultimately reject the article if it is of insufficient quality, has objective errors or if the authors were unreasonably unwilling to address the points raised during the review.

Chief Editors can at any stage of the peer-review step in to comment on the review process, change assigned editors, assign themselves as a reviewer and even as the handling editor for the manuscript, and therefore have full authority and all the mechanisms to act independently in their online editorial office to ensure quality.

Safeguards against Financial Conflicts of Interest

Only leading researchers acting as Associate Editors, who are not part of Frontiers staff, can make acceptance decisions based on reviews performed by external experts acting as Review Editors or reviewers. None have a financial incentive to accept articles, i.e. they are not paid for their role to act as Associate or Review Editors, and any award scheme is not linked to acceptances of manuscripts.

Chief Editors receive an honorarium if their specialty section or field reaches certain submission levels. However, this honorarium is based on the total number of submitted articles during a calendar year, and not the number of accepted articles. Therefore they also have no financial incentive to accept manuscripts.

Post-Publication Stage Quality

The Frontiers platform enables post-publication commenting and discussions on papers and hence the possibility to critically evaluate articles even after the peer-review process.

Frontiers has a community retraction protocol in place to retract papers where serious concerns have been raised and validated by the community that warrant retraction, including ethical concerns, honest errors or scientific misconduct.

Aside Side menu navigation

About this journal

Field chief editor

Mission & scope

Facts

Journal sections

Open access statement

Quality

Menu Footer Guidelines Author guidelinesEditor guidelinesPolicies and publication ethicsFee policy Explore ArticlesResearch Topics Journals Outreach Frontiers Forum Frontiers Policy Labs Frontiers for Young Minds Connect Help centerEmails and alerts Contact us SubmitCareer opportunities Follow us © 2024 Frontiers Media S.A. All rights reserved Privacy policy | Terms and conditions